Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 234 Breast Neoplasms 132 Neoplasms 97 Prostatic Neoplasms 34 Fatigue 34 Obesity 24 Lung Neoplasms 23 Colorectal Neoplasms 22 Polycystic Ovary Syndrome 17 Ovarian Neoplasms 13 Colonic Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Pancreatic Neoplasms 11 Lymphoma 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Rectal Neoplasms 10 Multiple Myeloma 10 Lymphedema 10 Hematologic Neoplasms 10 Head and Neck Neoplasms 10 Leukemia 9 Insulin Resistance 8 Cardiotoxicity 8 Brain Neoplasms 8 Stomach Neoplasms 7 Peripheral Nervous System Diseases 7 Overweight 6 Esophageal Neoplasms 6 Cognitive Dysfunction 6

Interventions

Adalimumab 13 Methotrexate 11 Etanercept 10 Rituximab 5 Abatacept 5 tocilizumab 4 olokizumab 4 tofacitinib 3 golimumab 3 Infliximab 3 Tumor Necrosis Factor Inhibitors 2 Saline Solution 2 RC-18 2 Nivolumab 2 Leflunomide 2 Certolizumab Pegol 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 cabozantinib 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Vaccines 1 TACI receptor-IgG Fc fragment fusion protein 1 Syringes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Arthritis, Rheumatoid × Exercise × Clear all

NCT05215509 2024-02-02

RABEX

Rigshospitalet, Denmark

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡